Clinical Trial

Efficacy and Safety of Oral NBP Soft Capsules for the Prevention of Episode Migraine Attacks in Adult Migraine Patients

Study acronym: ENERGY
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This is a multicentre, randomised, double-blind, placebo-controlled study to evaluate the efficacy, safety and tolerability of oral butylphthalide soft capsules for the prophylactic treatment of migraine in adults.
Trial Details
NCT Number NCT06968429
Lead Sponsor Chinese PLA General Hospital
Collaborators: Peking University First Hospital, First Affiliated Hospital of Chongqing Medical University, The People's Hospital of Hebei Province, The First Hospital of Jilin University, The First Affiliated Hospital of Shanxi Medical University, Guizhou Provincial People's Hospital
Conditions Migraine
Enrollment 500 participants
Start Date 2025-05
Primary Completion 2027-12 (estimated)
Study Completion 2028-12 (estimated)
Updated on ClinicalTrials.gov 2025-05-13